A new study reveals that blockbuster anti-obesity drugs improve heart health regardless of weight loss. Patients taking the drug experienced fewer heart attacks and strokes, with benefits seen in both marginally overweight and obese individuals. The study, funded by Novo Nordisk, found that the heart benefits are not directly linked to weight loss. Researchers advocate for broader access to the drug while noting the importance of investigating potential side effects. Teljes cikk (Euronews.com)